Literature DB >> 20713357

Maspin regulates endothelial cell adhesion and migration through an integrin signaling pathway.

Li Qin1, Ming Zhang.   

Abstract

Maspin has been identified as a potent angiogenesis inhibitor. However, the molecular mechanism responsible for its anti-angiogenic property is unclear. In this study, we examined the effect of maspin on endothelial cell (EC) adhesion and migration in a cell culture system. We found that maspin was expressed in blood vessels ECs and human umbilical vein endothelial cells (HUVECs). Maspin significantly enhanced HUVEC cell adhesion to various matrix proteins. This effect was dependent on the activation of integrin β(1), which subsequently led to distribution pattern changes of vinculin and F-actin. These results indicated that maspin affects cell adhesion and cytoskeleton reorganization through an integrin signal transduction pathway. Analysis of HUVECs following maspin treatment revealed increased integrin-linked kinase activities and phosphorylated FAK levels, consistent with increased cell adhesion. Interestingly, when HUVECs were induced to migrate by migration stimulatory factor bFGF, active Rac1 and cdc42 small GTPase levels were decreased dramatically at 30 min following maspin treatment. Using phosphorylated FAK at Tyr(397) as an indicator of focal adhesion disassembly, maspin-treated HUVECs had elevated FAK phosphorylation compared with the mock treated control. The results were a reduction in focal adhesion disassembly and the retardation in EC migration. This study uncovers a mechanism by which maspin exerts its effect on EC adhesion and migration through an integrin signal transduction pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713357      PMCID: PMC2952237          DOI: 10.1074/jbc.M110.131045

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  mMaspin: the mouse homolog of a human tumor suppressor gene inhibits mammary tumor invasion and motility.

Authors:  M Zhang; S Sheng; N Maass; R Sager
Journal:  Mol Med       Date:  1997-01       Impact factor: 6.354

2.  Involvement of microtubules in the control of adhesion-dependent signal transduction.

Authors:  A Bershadsky; A Chausovsky; E Becker; A Lyubimova; B Geiger
Journal:  Curr Biol       Date:  1996-10-01       Impact factor: 10.834

3.  Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.

Authors:  M Zhang; N Maass; D Magit; R Sager
Journal:  Cell Growth Differ       Date:  1997-02

4.  A novel approach to the identification of genes involved in neo-angiogenesis: implications for graft re-vascularization.

Authors:  M A Impagnatiello; E Bianchi; R Di Stefano; R Pardi; F Mosca
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

5.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Authors:  S Sheng; J Carey; E A Seftor; L Dias; M J Hendrix; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Production, purification, and characterization of recombinant maspin proteins.

Authors:  S Sheng; P A Pemberton; R Sager
Journal:  J Biol Chem       Date:  1994-12-09       Impact factor: 5.157

7.  Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

Authors:  Z Zou; A Anisowicz; M J Hendrix; A Thor; M Neveu; S Sheng; K Rafidi; E Seftor; R Sager
Journal:  Science       Date:  1994-01-28       Impact factor: 47.728

Review 8.  Maspin: a tumor suppressing serpin.

Authors:  R Sager; S Sheng; P Pemberton; M J Hendrix
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

9.  Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase.

Authors:  G E Hannigan; C Leung-Hagesteijn; L Fitz-Gibbon; M G Coppolino; G Radeva; J Filmus; J C Bell; S Dedhar
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

10.  The tumor suppressor maspin does not undergo the stressed to relaxed transition or inhibit trypsin-like serine proteases. Evidence that maspin is not a protease inhibitory serpin.

Authors:  P A Pemberton; D T Wong; H L Gibson; M C Kiefer; P A Fitzpatrick; R Sager; P J Barr
Journal:  J Biol Chem       Date:  1995-06-30       Impact factor: 5.157

View more
  22 in total

1.  Id1-induced inhibition of p53 facilitates endothelial cell migration and tube formation by regulating the expression of beta1-integrin.

Authors:  Juhui Qiu; Guixue Wang; Jianjun Hu; Qin Peng; Yiming Zheng
Journal:  Mol Cell Biochem       Date:  2011-06-01       Impact factor: 3.396

2.  Internalization by multiple endocytic pathways and lysosomal processing impact maspin-based therapeutics.

Authors:  Thomas M Bodenstine; Richard E B Seftor; Elisabeth A Seftor; Zhila Khalkhali-Ellis; Nicole A Samii; J Cesar Monarrez; Grace S Chandler; Philip A Pemberton; Mary J C Hendrix
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

3.  Recombinant human maspin inhibits high glucose-induced oxidative stress and angiogenesis of human retinal microvascular endothelial cells via PI3K/AKT pathway.

Authors:  Feng Qiu; Huijuan Tong; Yawen Wang; Jun Tao; Hailin Wang; Lei Chen
Journal:  Mol Cell Biochem       Date:  2018-01-23       Impact factor: 3.396

4.  Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.

Authors:  Li Qin; Xian Chen; Yelin Wu; Zhen Feng; Tao He; Li Wang; Lan Liao; Jianming Xu
Journal:  Cancer Res       Date:  2011-02-22       Impact factor: 12.701

5.  Maspin suppresses cell invasion and migration in gastric cancer through inhibiting EMT and angiogenesis via ITGB1/FAK pathway.

Authors:  Ning Wang; Li-Li Chang
Journal:  Hum Cell       Date:  2020-05-14       Impact factor: 4.174

6.  Maspin, the molecular bridge between the plasminogen activator system and beta1 integrin that facilitates cell adhesion.

Authors:  Michael P Endsley; Yanqiu Hu; Yong Deng; Xiaolin He; Debra J Warejcka; Sally S Twining; Steven L Gonias; Ming Zhang
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 7.  Self-assembling peptide-based building blocks in medical applications.

Authors:  Handan Acar; Samanvaya Srivastava; Eun Ji Chung; Mathew R Schnorenberg; John C Barrett; James L LaBelle; Matthew Tirrell
Journal:  Adv Drug Deliv Rev       Date:  2016-08-14       Impact factor: 15.470

8.  Clinical value of Tiam1-Rac1 signaling in primary gallbladder carcinoma.

Authors:  Xilin Du; Shengzhi Wang; Jianguo Lu; Qing Wang; Nuan Song; Tao Yang; Rui Dong; Li Zang; Yuan Yang; Tao Wu; Chengguo Wang
Journal:  Med Oncol       Date:  2011-08-19       Impact factor: 3.064

9.  Tumor-suppressive maspin functions as a reactive oxygen species scavenger: importance of cysteine residues.

Authors:  Nitin Mahajan; Heidi Y Shi; Thomas J Lukas; Ming Zhang
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

10.  Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging.

Authors:  Stefano Tarantini; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Peter Toth; Tripti Gautam; Cory B Giles; Praveen Ballabh; Jeanne Y Wei; Jonathan D Wren; Nicole M Ashpole; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  Age (Dordr)       Date:  2016-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.